Ikarian Capital’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-58,526
| Closed | -$126K | – | 134 |
|
|
2025
Q1 | $126K | Hold |
58,526
| – | – | 0.02% | 105 |
|
|
2024
Q4 | $226K | Sell |
58,526
-2
| -0% | -$8 | 0.03% | 102 |
|
|
2024
Q3 | $383K | Sell |
58,528
-265,000
| -82% | -$1.74M | 0.05% | 77 |
|
|
2024
Q2 | $2.35M | Sell |
323,528
-115,000
| -26% | -$834K | 0.41% | 34 |
|
|
2024
Q1 | $3.33M | Sell |
438,528
-164,340
| -27% | -$1.25M | 0.36% | 31 |
|
|
2023
Q4 | $2.74M | Sell |
602,868
-80,000
| -12% | -$364K | 0.26% | 32 |
|
|
2023
Q3 | $2.7M | Buy |
+682,868
| New | +$2.7M | 0.32% | 28 |
|
|
2022
Q3 | – | Sell |
-51,606
| Closed | -$100K | – | 98 |
|
|
2022
Q2 | $100K | Hold |
51,606
| – | – | 0.02% | 90 |
|
|
2022
Q1 | $209K | Buy |
51,606
+4,413
| +9% | +$17.9K | 0.03% | 125 |
|
|
2021
Q4 | $510K | Hold |
47,193
| – | – | 0.08% | 96 |
|
|
2021
Q3 | $545K | Sell |
47,193
-5,775
| -11% | -$66.7K | 0.04% | 118 |
|
|
2021
Q2 | $520K | Sell |
52,968
-372,416
| -88% | -$3.66M | 0.04% | 133 |
|
|
2021
Q1 | $6.22M | Buy |
+425,384
| New | +$6.22M | 0.21% | 34 |
|